 | A major contributor to this article appears to have a close connection with its subject. (December 2019) |
 | |
| Company type | Private |
|---|---|
| Industry | Biopharmaceutical |
| Founded | 1998 |
| Headquarters |  Omaha, Nebraska |
Key people | Jeeri R. Reddy, Founder |
| Products | Vaccines, Diagnostics |
| Website | http://www.jn-vaccines.com |
JN-International Medical Corporation (JNIMC) is a U.S.-based biopharmaceutical corporation which since 1998 has been focused on developing vaccines and diagnostics for infectious disease for developing countries. This private corporation (formerly known as Jeeri Neotech International, Inc) was founded in 1998 by Dr. Jeeri R. Reddy with the help of Dr. Kelly F. Lechtenberg in a small rural town, Oakland, Nebraska. From there it grew and expanded until in the year 2000 the corporation moved to Omaha, Nebraska.
JNIMC partners with Global Health Organizations such as the Clinton Global Initiative,[1] the Global Business Coalition, New York, President's Malaria Initiative (PMI),[2][3] The Global Health Council, NGOs, local governments and communities in developing countries to address the health issues related to HIV AIDS, malaria, tuberculosis, and bacterial meningitis that affect the underserved communities in West Africa, South East Asia, and Latin America.
- ^ "Development and Production of Low-Cost Vaccines". Clinton Foundation. Retrieved 10 August 2018.
- ^ "New Page 15". Archived from the original on 2016-03-02. Retrieved 2015-09-18.
- ^ "Home - PMI". Pmi.gov. Retrieved 10 August 2018.